Early and Equitable Fast Access (EEFA): Framework, Process & Practice

Join this focused session on EEFA to get practical, insider guidance by experts from the authorities.

66 Attendees (including 15 not visible)
Last name First name Organization
Benard Audrey Pfizer N.V. – S.A.
Bertier Laurence IPSEN nv
Berx Brently Kintiga (AxTalis BV)
Block Sebastien -
Boeren Marlies Kintiga (AxTalis BV)
Brenez Valerie Astellas Pharma (Belux) BV
Coppenrath Marilyn -
Coucke Dicky Roche
D'haene Barbara LIVV - Two Point Zero Consultancy BV
D'hulster Erinn Axes Health BV
Daissormont Isabelle Amgen Belgium nv
Debie Pieterjan MSD Belgium SRL
Debrulle Jens Novartis Pharma nv
Eykens Johan EA Consultants BV
Fiawoo Maelys MSD Belgium SRL
Gellynck Kris NORGINE nv/sa
Gillain Gaëtane Gaëtane Gillain
Houbracken Katrijn Takeda Belgium NV
Huybrechts Sofie Biogen Belgium NV/SA
Ismailaj Daniela ROCHE sa/nv
Iven Julie AstraZeneca nv/sa
Jansen Mieke Novartis Pharma nv
Khaouiry Asmae Axes Health BV
Kinoo Dominique AstraZeneca nv/sa
Lambert Bernard ROCHE sa/nv
Leroi Hermine MSD Europe Belgium SRL
Libert Cédric GILEAD Sciences Belgium bv
Maes Ariane Janssen-Cilag NV
Marinovic Ines Teva Pharma Belgium
Mentens Ruth Takeda Belgium NV
Neckebroeck Wim Kintiga (AxTalis BV)
Niclaus Nathalie Themi Consulting
Pardaens Hannah SCS Boehringer Ingelheim Comm.V
Paternotte Nathalie AstraZeneca nv/sa
Ricci Monica Kintiga (AxTalis BV)
Sebti Nizar ROCHE sa/nv
Suteniec Caroline FAMHP
Van der veken Bieke ROCHE sa/nv
Van der Veken Katrien AstraZeneca nv/sa
Van Erck Frank SERVIER R&D BENELUX
Van Steendam Sofie Daiichi Sankyo Belgium
Vandebrouck Tom Vandebrouck Coaching and consulting
Vandyck Glen GILEAD Sciences Belgium bv
Vansteelant Lore UZ Gent
Venken Katrien Organon Belgium BV
Verhaegen Sofie Biogen
Verhaeghe Sarah Amgen Belgium nv
Verheecke Annouk Kintiga (AxTalis BV)
Vermander Sofie Kintiga (AxTalis BV)
Vierin Laurent MSD Europe Belgium SRL
Willaert Marjan pharma.be VZW

Attendees at Early and Equitable Fast Access (EEFA): Framework, Process & Practice